Skip to content
DeepViews

The Chemours Company (CC) — Analysis Summary

The Chemours Company (CC) has a market cap of $2.35B with year-over-year revenue growth of +0.4%. Net margin stands at -6.6%. The stock trades at a P/E ratio of -7.7.

Key Takeaways

  • Revenue changed +0.4% year-over-year
  • Net margin of -6.6%
  • P/E ratio of -7.7

Compared to other companies in the CHEMICALS & ALLIED PRODUCTS sector, CC posted revenue growth of +0.4% and trades at a P/E of -7.7.

[XNYS]

The Chemours Company (CC)

$15.62

UPDATED — ET · MARKET DATA POLYGON · FINANCIALS SEC EDGAR

Market Cap
$2350.79M
Enterprise Value
$5593.79M
P/E Ratio
-7.7
Div Yield
2.24%
EV/EBITDA
10.1
Company Profile
About
About The Chemours Company

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, paints and coatings, plastics, transportation, semiconductor, and others. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

Sector

CHEMICALS & ALLIED PRODUCTS

Employees

5,700

Headquarters

WILMINGTON, DE

Exchange

XNYS

Website
Source: Polygon.io
Score
Competitive Moat
Competitive Moat
28
No Moat

Systematic competitive advantage assessment based on 4yr data

This assessment is based on quantitative analysis of historical financial data and does not constitute investment advice. Moat ratings may change with industry and competitive dynamics.

Market Signals
Valuation
Earnings
Insider Activity
Insider Filing Activity

First version surfaces recent SEC Forms 3, 4, and 5 activity. It does not yet parse individual buy/sell transactions.

Loading SEC insider filing activity...
Superinvestors
Financial Health
Financial Health

Capital Structure

Total Equity$-48.00M
Total Debt$3914.00M
Debt-to-EquityN/A
Cash & Equivalents$671.00M

Cash Flow

Operating Cash Flow$397.00M
Free Cash Flow$218.00M
FCF Margin3.76%
P/FCF Ratio10.78
Source: Polygon.io · SEC EDGAR
Dividends
Dividends

Annual Dividend/Share

$0.35

Dividend Yield

2.24%

Quarterly
Last Ex-Date: 2026-08-14

Dividend History

2026-08-14
CD$0.0875
2026-05-15
CD$0.0875
2026-02-27
CD$0.0875
2025-11-14
CD$0.0875
Source: Polygon.io
Recent News
Recent News

Disclaimer: This is not financial advice. Data sourced from SEC EDGAR and Polygon.io. Past performance does not guarantee future results. Always conduct your own research before making investment decisions.